Gan & Lee Pharmaceuticals. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 1,709.87 million compared to CNY 3,611.93 million a year ago.

Revenue was CNY 1,712.27 million compared to CNY 3,612.04 million a year ago. Net loss was CNY 439.52 million compared to net income of CNY 1,452.75 million a year ago. Basic loss per share from continuing operations was CNY 0.78 compared to basic earnings per share from continuing operations of CNY 2.59 a year ago.

Diluted loss per share from continuing operations was CNY 0.78 compared to diluted earnings per share from continuing operations of CNY 2.59 a year ago.